Literature DB >> 9501891

Valproate monotherapy in an SRI-intolerant OCD patient.

G Corá-Locatelli, B D Greenberg, J D Martin, D L Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9501891     DOI： 10.4088/jcp.v59n0207b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  8 in total

Review 1.  Anticonvulsants in anxiety disorders.

Authors:  Gustavo Kinrys; Lisa E Wygant
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

2.  Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?

Authors:  Emin Onder; Umit Tural; Mehmet Gökbakan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

Review 3.  Antiepileptic drugs in the treatment of anxiety disorders: role in therapy.

Authors:  Michael Van Ameringen; Catherine Mancini; Beth Pipe; Mark Bennett
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Epidemiology and management of anxiety in patients with bipolar disorder.

Authors:  Marcia Kauer-Sant'Anna; Flavio Kapczinski; Eduard Vieta
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

5.  Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.

Authors:  Nigel Whittle; Claudia Schmuckermair; Ozge Gunduz Cinar; Markus Hauschild; Francesco Ferraguti; Andrew Holmes; Nicolas Singewald
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

Review 6.  Drug treatment of obsessive-compulsive disorder.

Authors:  Michael Kellner
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

Review 7.  Management of obsessive-compulsive disorder comorbid with bipolar disorder.

Authors:  Firoz Kazhungil; E Mohandas
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759

Review 8.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.